SCICLONE PHARMA News

Saisheng Pharmaceutical (06600): 15,000 share options have been exercised

Saisheng Pharmaceutical (06600) announced that on May 14, 2024, it will be granted under the initial public offering after-sales share purchase option plan...

Zhitong FinanceMay 14 21:51

Express News | Galaxy Securities: Judging from the pace of the industry's revenue growth rate, the first quarter of 2024 is expected to be the lowest point in the pharmaceutical industry in the whole year

BreakingsMay 14 09:05

Saisheng Pharmaceutical (06600): 122,500 share options exercised

Saisheng Pharmaceutical (06600) issued an announcement. On May 13, 2024, according to the initial public offering after-sales share purchase options...

Zhitong FinanceMay 13 21:11

The medical news is huge! Will Pharmacokinetics usher in a turning point? US pharmaceutical company contract exemption or extension for 8 years

Industry insiders believe that 8 years is enough time for relevant companies to adapt, and the implementation of this greatest uncertainty can also have a positive impact on related companies.

券商中國May 13 09:03

Saisheng Pharmaceutical (06600): A total of 42,000 share options have been exercised

Saisheng Pharmaceutical (06600) issued an announcement. On May 10, 2024, it was awarded 1 in accordance with the share purchase incentive plan...

Zhitong FinanceMay 10 22:33

Express News | Saisheng Pharmaceutical: 35,000 share options exercised

BreakingsMay 8 21:23

Saisheng Pharmaceutical (06600.HK): 35,000 share options exercised

Saisheng Pharmaceutical (06600.HK) announced that on May 8, 2024, the 35,000 share options granted under the initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.

Zhitong FinanceMay 8 21:20

Saisheng Pharmaceutical (06600): 35,000 share options exercised

Saisheng Pharmaceutical (06600) announced that on May 8, 2024, it was awarded under the initial public offering after-sales share purchase option plan...

Zhitong FinanceMay 8 21:19

Saisheng Pharmaceutical (06600): 90,000 share options have been exercised

Saisheng Pharmaceutical (06600) announced that on May 7, 2024, in accordance with the rules of the initial public offering after-sales share purchase option plan...

Zhitong FinanceMay 7 22:32

Express News | Guotai Junan: Pharmaceutical industry prosperity is expected to continue to improve

BreakingsMay 7 14:11

Saisheng Pharmaceutical (06600): 105,500 share options exercised

Saisheng Pharmaceutical (06600) issued an announcement on May 6, 2024, according to the initial public offering after-sales share purchase option plan...

Zhitong FinanceMay 6 22:40

Data reveal | What did Beishui buy in April? Bank of China sold over HK$10.5 billion and Tencent raised over HK$5.3 billion

Since July 2023, the southbound capital has maintained a net inflow for 10 consecutive months, with a cumulative net purchase of HK$408.792 billion during this period.

Futu NewsMay 1 10:15

Saisheng Pharmaceutical (06600): 10,000 share options have been exercised

Saisheng Pharmaceutical (06600) issued an announcement. On April 30, 2024, according to the initial public offering after-sales share purchase options...

Zhitong FinanceApr 30 22:30

賽生藥業：2023年報

Futu NewsApr 29 16:33 · Announcements

Saisheng Pharmaceutical (06600): 286,400 share options have been exercised

According to the Zhitong Finance App, Saisheng Pharmaceutical (06600) announced that on April 26, 2024, the 286,400 share options granted under the company's initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.

Zhitong FinanceApr 26 21:47

Saisheng Pharmaceutical (06600): 7,500 share options have been exercised

Saisheng Pharmaceutical (06600) issued an announcement. On April 23, 2024, the company's initial public offering of after-sales share purchase options...

Zhitong FinanceApr 23 22:25

Statistics on changes in the share of Zhitong Hong Kong Stock Connect | April 23

According to data disclosed on April 22, 2024, Weimeng Group (02013.HK), CGN Power (01816.HK), and Yingfu Fund (02800.HK) had the largest share increase in value, increasing 0.88%, 0.73%, and 0.64% respectively; Follett Glass (06865.HK), Elegant Life Services (03319.HK), and Saisheng Pharmaceutical (06600.HK) Hong Kong Stock Connect shares decreased the most, decreasing by -0.68%, -0.63%, -0.63%, respectively 4%

Zhitong FinanceApr 23 08:36

Saisheng Pharmaceutical (06600.HK): 90,000 share options exercised

Saisheng Pharmaceutical (06600.HK) announced that on April 22, 2024, the 90,000 share options granted under the company's initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.

Zhitong FinanceApr 22 22:01

Saisheng Pharmaceutical (06600): 60,600 share options have been exercised

According to the Zhitong Finance App, Saisheng Pharmaceutical (06600) announced that on April 19, 2024, according to the rules of the initial public offering after-sales share option plan, the 86,400 share options granted under the initial public offering after-sales share option plan have expired; and the 60,600 share options granted under the initial public offering after-sales share option plan have been exercised.

Zhitong FinanceApr 19 22:52

Sciclone Pharmaceuticals to Dispatch Privatization Documents by May 31

Sciclone Pharmaceuticals (Holdings) (HKG:6600) sought an extension for the dispatch of the scheme document related to its privatization as it needs more time to finalize the document's content. The bi

MT NewswiresApr 18 21:21